Ionis to present at TD Cowen Genetic Medicines & RNA Summit

Rhea-AI Summary

Ionis Pharmaceuticals announced that its management will participate in a fireside chat at the TD Cowen Genetic Medicines & RNA Summit on June 20, 2024. The event will be virtual, and a live webcast will be available on the Ionis website. Interested parties can access the webcast on the Investors & Media section of the website, with a replay available within 48 hours for a time.

Positive

• Ionis Pharmaceuticals' participation in the TD Cowen Genetic Medicines & RNA Summit increases visibility in the industry.
• Hosting a virtual fireside chat allows broader access to potential investors and stakeholders.
• Availability of a live webcast and replay enhances transparency and investor engagement.

Negative

• replay availability may restrict access for those unable to attend the live event.

CARLSBAD, Calif., June 17, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a fireside chat at the virtual TD Cowen Genetic Medicines & RNA Summit on Thursday, June 20, 2024.

A live webcast of this presentation can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – ir@ionis.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-td-cowen-genetic-medicines--rna-summit-302174669.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

What event is Ionis Pharmaceuticals participating in on June 20, 2024?

Ionis Pharmaceuticals will participate in a fireside chat at the virtual TD Cowen Genetic Medicines & RNA Summit on June 20, 2024.

How can I access the Ionis Pharmaceuticals presentation at the TD Cowen Genetic Medicines & RNA Summit?

The live webcast of the presentation can be accessed on the Investors & Media section of the Ionis website.

Will there be a replay available for the Ionis Pharmaceuticals presentation at the TD Cowen Genetic Medicines & RNA Summit?

Yes, a replay will be available on the Ionis website within 48 hours after the live event and will be archived for a time.

What is the significance of the TD Cowen Genetic Medicines & RNA Summit for Ionis Pharmaceuticals (IONS)?

Participation in the TD Cowen Genetic Medicines & RNA Summit provides Ionis Pharmaceuticals with increased visibility and engagement with investors and stakeholders in the genetic medicines and RNA space.